Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C24H34O6S |
| Molecular Weight | 450.588 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 4 / 4 |
| E/Z Centers | 1 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
COCC1=CC(C[C@H](O)\C=C\[C@H]2[C@H](O)CC(=O)[C@@H]2CCSCCCC(=O)OC)=CC=C1
InChI
InChIKey=FBQUXLIJKPWCAO-AZIFJQEOSA-N
InChI=1S/C24H34O6S/c1-29-16-18-6-3-5-17(13-18)14-19(25)8-9-20-21(23(27)15-22(20)26)10-12-31-11-4-7-24(28)30-2/h3,5-6,8-9,13,19-22,25-26H,4,7,10-12,14-16H2,1-2H3/b9-8+/t19-,20-,21-,22-/m1/s1
| Molecular Formula | C24H34O6S |
| Molecular Weight | 450.588 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 4 / 4 |
| E/Z Centers | 1 |
| Optical Activity | UNSPECIFIED |
Rivenprost (ONO-4819) is a potent and selective EP4 receptor agonist. This compound can increase bone formation by stimulating osteoblast differentiation and function, possibly by modulating mesenchymal cell differentiation. Rivenprost has also been studied for its potential to prevent bone loss (in osteoporosis) and stabilize bone implants. Combined with risedronate, rivenprost may be an effective treatment for osteoporosis. A phase II study evaluating rivenprost in ulcerative colitis was terminated in 2009.
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Wed Apr 02 09:23:56 GMT 2025
by
admin
on
Wed Apr 02 09:23:56 GMT 2025
|
| Record UNII |
1WBO45T413
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C78568
Created by
admin on Wed Apr 02 09:23:56 GMT 2025 , Edited by admin on Wed Apr 02 09:23:56 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
C87384
Created by
admin on Wed Apr 02 09:23:56 GMT 2025 , Edited by admin on Wed Apr 02 09:23:56 GMT 2025
|
PRIMARY | |||
|
CHEMBL303960
Created by
admin on Wed Apr 02 09:23:56 GMT 2025 , Edited by admin on Wed Apr 02 09:23:56 GMT 2025
|
PRIMARY | |||
|
8601
Created by
admin on Wed Apr 02 09:23:56 GMT 2025 , Edited by admin on Wed Apr 02 09:23:56 GMT 2025
|
PRIMARY | |||
|
9803828
Created by
admin on Wed Apr 02 09:23:56 GMT 2025 , Edited by admin on Wed Apr 02 09:23:56 GMT 2025
|
PRIMARY | |||
|
DTXSID601101764
Created by
admin on Wed Apr 02 09:23:56 GMT 2025 , Edited by admin on Wed Apr 02 09:23:56 GMT 2025
|
PRIMARY | |||
|
256382-08-8
Created by
admin on Wed Apr 02 09:23:56 GMT 2025 , Edited by admin on Wed Apr 02 09:23:56 GMT 2025
|
PRIMARY | |||
|
300000034387
Created by
admin on Wed Apr 02 09:23:56 GMT 2025 , Edited by admin on Wed Apr 02 09:23:56 GMT 2025
|
PRIMARY | |||
|
1WBO45T413
Created by
admin on Wed Apr 02 09:23:56 GMT 2025 , Edited by admin on Wed Apr 02 09:23:56 GMT 2025
|
PRIMARY | |||
|
406692-60-2
Created by
admin on Wed Apr 02 09:23:56 GMT 2025 , Edited by admin on Wed Apr 02 09:23:56 GMT 2025
|
SUPERSEDED |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
METABOLITE ACTIVE -> PRODRUG |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
ACTIVE MOIETY |
|